Atlas Trials

Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion

Clinical trial NCT02673138 · COMPLETED

Trial details

NCT number
NCT02673138
Sponsor
Yale University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2016-01-01
Primary completion
2017-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.